Global Strategic Product
Acquisitions and Co-Developments
With a focus on China's high-incidence cancers and the needs of Chinese patients, in-license attractive assets globally or custom design and develop through preclinical CROs
World-ClassLeverage the clinical team's industry-leading capabilities to accelerate clinical development & drug registration, while adhering to international standards and quality
Commercialize Products in China and Globally
Build internal commercial infrastructure in China
Co-develop and co-market outside China
To ensure quality, CStone keeps the most critical clinical development functions in-house; while collaborating with the best CROs to lower operating costs and conduct multiple clinical trials simultaneously
Leverage an innovative model to shorten the timeline for clinical development
